Home » Stocks » ACCD

Accolade, Inc. (ACCD)

Stock Price: $52.35 USD 0.00 (0.00%)
Updated Jan 15, 2021 4:00 PM EST - Market closed
After-hours: $52.00 -0.35 (-0.67%) Jan 15, 7:40 PM
Market Cap 2.90B
Revenue (ttm) 155.57M
Net Income (ttm) -48.07M
Shares Out 51.58M
EPS (ttm) -0.93
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 15
Last Price $52.35
Previous Close $52.35
Change ($) 0.00
Change (%) 0.00%
Day's Open 53.10
Day's Range 51.06 - 54.60
Day's Volume 2,546,626
52-Week Range 29.70 - 59.72

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
PYMNTS - 3 days ago

Healthcare technology company Accolade is buying telemedicine startup 2nd.MD to boost its abilities to help users navigate medical plans and second options, CNBC reported. The sale is likely t...

GeekWire - 3 days ago

Seattle-based Accolade announced Thursday that it will pay $460 million acquire 2nd.

Market Watch - 3 days ago

Accolade Inc. said late Thursday it has agreed to buy Innovation Specialists LLC, which does business as 2nd.MD, a "leading" expert medical opinion and medical decision support company based i...

GlobeNewsWire - 3 days ago

The addition of 2nd.MD's Expert Medical Opinion services to Accolade's portfolio of high-touch, technology-enabled health and benefits solutions expands Accolade's clinical capabilities and cr...

CNBC - 3 days ago

Just as the digitization of finance has attracted billions in investment and a flurry of M&A, health tech has seen a surge in interest during the pandemic.

Seeking Alpha - 5 days ago

Accolade integrates workplace benefits into one platform and helps organizations save on employee healthcare costs through a virtual concierge service. The company launched its IPO in July of ...

GlobeNewsWire - 1 week ago

SEATTLE, Jan. 11, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize th...

Seeking Alpha - 1 week ago

Accolade, Inc. (ACCD) CEO Rajeev Singh on Q3 2021 Results - Earnings Call Transcript

GlobeNewsWire - 1 week ago

SEATTLE, Jan. 07, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize th...

GlobeNewsWire - 3 weeks ago

SEATTLE, Dec. 23, 2020 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize th...

GlobeNewsWire - 1 month ago

SEATTLE, Dec. 17, 2020 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize th...

GlobeNewsWire - 1 month ago

SEATTLE, Nov. 20, 2020 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize th...

GlobeNewsWire - 2 months ago

SEATTLE, Oct. 28, 2020 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize th...

GlobeNewsWire - 2 months ago

SEATTLE, Oct. 26, 2020 (GLOBE NEWSWIRE) -- Accolade, Inc. (Nasdaq: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize th...

GlobeNewsWire - 2 months ago

SEATTLE, Oct. 21, 2020 (GLOBE NEWSWIRE) -- Accolade, Inc. (“Accolade”), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the ...

GlobeNewsWire - 2 months ago

SEATTLE, Oct. 19, 2020 (GLOBE NEWSWIRE) -- Accolade, Inc. (“Accolade”), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the ...

Seeking Alpha - 3 months ago

Accolade, Inc. (ACCD) CEO Rajeev Singh on Q2 2021 Results - Earnings Call Transcript

GeekWire - 3 months ago

Health benefits technology company Accolade saw revenue rise 24% in the most recent quarter as telehealth usage surges amid the COVID-19 pandemic.

GlobeNewsWire - 3 months ago

SEATTLE, Oct. 14, 2020 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize th...

GlobeNewsWire - 3 months ago

SEATTLE, Sept. 24, 2020 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize...

GeekWire - 4 months ago

Health benefits technology company Accolade says it will provide access to mental health support, including on-demand virtual therapy, in partnership with mental health service Ginger. The par...

GlobeNewsWire - 4 months ago

SEATTLE, Sept. 01, 2020 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize...

Seeking Alpha - 5 months ago

Accolade's (ACCD) CEO Rajeev Singh on Q1 2021 Results - Earnings Call Transcript

GeekWire - 5 months ago

Seattle entrepreneur and former Concur president Raj Singh was back in the earnings hot seat Thursday afternoon as the CEO of Accolade, walking analysts and investors through the health benefi...

GlobeNewsWire - 5 months ago

SEATTLE, Aug. 13, 2020 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize ...

GlobeNewsWire - 5 months ago

SEATTLE, July 27, 2020 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize ...

Newsfile Corp - 5 months ago

The Landmark Deal Will Include Geyser Peak, Atlas Peak, XYZin and Outlot WinesNapa, California--(Newsfile Corp. - July 23, 2020) -  Family owned-and-operated fine wine importer Quintessential ...

PRNewsWire - 6 months ago

SEATTLE, July 7, 2020 /PRNewswire/ -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the hea...

GeekWire - 6 months ago

Accolade’s share price is up 38% since its initial public offering on Thursday, marking a successful debut for the health benefits management company at a time of unprecedented uncertainty in ...

Seeking Alpha - 6 months ago

Accolade - Interesting Tech And Healthcare Offering

Seeking Alpha - 6 months ago

Three IPOs raised $2.3 billion this past week, led by Dun & Bradstreet's billion-dollar deal. All three IPOs upsized their deals and priced above the range.

Other stocks mentioned: DNB, LMND
TechCrunch - 6 months ago

Despite today’s bucket of plus-and-minus economic data, stocks are heading higher in regular trading. And among the shares rising the most are today’s two venture-backed IPOs: Lemonade and Acc...

Other stocks mentioned: LMND
CNBC Television - 6 months ago

Accolade CEO Rajeev Singh on the company's IPO

Rajeev Singh, CEO of Accolade, joins "Squawk on the Street" to discuss the company's IPO.

GeekWire - 6 months ago

Health benefits platform Accolade made its initial public offering Thursday morning, pricing its stock at $22/share, above the expected range of $19 to $21, and raising $220 million at a valua...

About ACCD

Accolade develops and provides technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and with multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. Its customers are primarily employers who provide their employees and their employees' families a single place to turn for their health, healthcare, ... [Read more...]

Industry
Health Information Services
IPO Date
Jul 2, 2020
Stock Exchange
NASDAQ
Ticker Symbol
ACCD
Full Company Profile

Financial Performance

In 2019, Accolade's revenue was $132.51 million, an increase of 39.76% compared to the previous year's $94.81 million. Losses were -$51.37 million, -9.08% less than in 2018.

Financial Statements

Analyst Forecasts

According to 12 analysts, the average rating for Accolade stock is "Buy." The 12-month stock price forecast is 54.36, which is an increase of 3.84% from the latest price.

Price Target
$54.36
(3.84% upside)
Analyst Consensus: Buy